The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro

Jürgen Sonnemann (1, 2) , Stephanie Gressmann (1) , Sabine Becker (1) , Susan Wittig (1) , Mareike Schmudde (3) , James F. Beck (1)

1 Department of Paediatric Haematology and Oncology
2 Klinik für Kinder- und Jugendmedizin
3 Institute for Immunology and Transfusion Medicine

Mots clés: Bortezomib; Calreticulin; Childhood brain tumour; Histone deacetylase inhibitor; TRAIL; Vorinostat

Jürgen Sonnemann, Stephanie Gressmann, Sabine Becker, Susan Wittig, Mareike Schmudde, et al.. The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro. Cancer Chemotherapy and Pharmacology, 2010, 66 (3), pp.611-616. ⟨10.1007/s00280-010-1302-4⟩. ⟨hal-00575248⟩